14 Nov

HealthBeacon signs agreement with Canada’s leading patient support provider, Innomar Strategies

HealthBeacon, partners with Innomar Strategies, to bring its smart sharps bin offering to Canada.

(DUBLIN, IE., TORONTO, ON. –November 14th, 2018) HealthBeacon announced today their partnership with Innomar Strategies to provide the HealthBeacon smart sharps bin and digital therapeutic platform to Canadian patients across the country.

HealthBeacon is a Dublin headquartered, digital therapeutic company that produces a smart sharps bin to track and drive medication adherence. Following their recent FDA clearance in the US, HealthBeacon has begun investing resources in the North American markets of the United States and Canada. Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market, helping patients navigate the complicated Canadian healthcare system, and providing support for their injections and infusions.

“We have seen great patient engagement with the HealthBeacon tool in Ireland. It has been instrumental in aiding us in identifying patients that need assistance, and helping drive adherence to their medication. I’m delighted to see they are making HealthBeacon available in Canada.” – Dr. Trevor Duffy, Rheumatologist

HealthBeacon began operations in Canada with the opening of their Montreal office in December 2016. HealthBeacon CEO, Jim Joyce commented, The Canadian market is a large market, both geographically and in terms of patients who could benefit from our technology. The signing of this partnership is a major milestone in making our technology accessible to the Canadian market.

As an industry leader, Innomar deeply understands the patient journey.  A core focus is delivering best-in-class care and education through patient services to monitor adherence and ensure optimal outcomes.

“We look forward to partnering with HealthBeacon as they move into the Canadian market.  Our focus is on patient care, and having a tool to track and facilitate medication adherence brings value to patient care across Canada,” says Amar Pabla, Vice President Nursing, Clinics and Pharmacovigilance.

“HealthBeacon are a fantastic example of Irish innovation. This partnership is testimony to the deepening links between Irish and Canadian healthcare. As the government agency driving the growth of Irish businesses internationally, we at Enterprise Ireland look forward to seeing HealthBeacon support Innomar Strategies in its mission to advance patient support across Canada.” – Neil Cooney, Country Manager Canada, Enterprise Ireland

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. The HealthBeacon is a smart sharps bin for patients who self-inject medications at home. It is digitally connected and programmed with a patient’s personal medication schedule, and uses customized reminders to help them start and stay on track with medication. The company is headquartered in Dublin, Ireland and has offices in the US and in Canada. Learn more at www.healthbeacon.com

About Innomar Strategies

Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment tobest-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes. Visit us at www.innomarstrategies.com.

31 Oct

HealthBeacon Builds Presence in Asia

HealthBeacon started off in Ireland piloting its technology with the local Irish divisions of pharmaceutical giants. These same great clients networked us into their global organisation which led to deployment of our HealthBeacon Medication Management technology across 10 Countries: USA, Canada, across the EU, South Africa, Baltics, Brazil, Israel and South Africa. We had to develop global organisational muscles early in our life, our clients made it a prerequisite. Now we are heading to Asia!

We will be featured on two panels at large Digital Health events in both Mumbai and Singapore.

The first will be a global gathering for HealthXL presented by Abbott and featuring panelists and speakers that include Arun Kumar, Head of South Asia for Bayer and Dr Arvind Sivaramakrishnan, Chief Information Officer at Apollo Hospitals

The second event is a panel about Digitising Patient Care featuring Jim Joyce, Everett Leonidas from Aviva Ventures which will be moderated by Susanna Hasenoehrl of Joice Nutrition and hosted by SG Innovate in Singapore.

In collaboration with these two great organisations, HealthXL and SG Innovate, we will begin  introducing ourselves and our technology into the Singapore, Australian and Indian markets. These three markets will become our first wave of Asia-Pac HealthBeacon deployments.

Operating a young technology company across 10 countries from our two office locations,  Dublin and Boston required us to leverage scaling technology platforms, find excellent local partners, build scalable roll-out processes that are all driven by a team that thinks globally.

 

HealthXL Global Gathering Mumbai

Date/Venue: 1st November 2018, 9:00am- 4:00pm

Bandra Kurla Complex Mumbai

Topics: 

  • Patient Centricity
  • Non-Communicable DiseaseDigital
  • Health Investments in India
  • Big Data to Improve Patient Outcomes

 

 

 

Digitising Patient Care- SG Innovate

Date/ Venue: 8th November 2018, 5:00pm- 7:00pm

32 Carpenter Street, Singapore 059911

In the midst of a patient data revolution, this panel will discuss the importance of caring for and facilitating patient data in a way that makes sense. Medtech and digital therapeutics are increasingly focused on patient centricity and care. Our leading experts will be focused on providing a vision for the future of patient care in a digital world.

 

 

25 Oct

HealthBeacon Sponsors Ireland’s Cancer Fund for Children

HealthBeacon will be supporting the Cancer Fund for Children as the “Speakeasy” Sponsor at this years’ Gala Ball. The Gala Ball is part of a 5-year program that aims to raise €1m for the Cancer Fund for Children. They are in large part supported by Ireland’s Digital Economy with its inaugural 2017 Gala Ball raising more than €137,000. The goal is to build a brand new therapeutic centre for children diagnosed with cancer, and their families, in Ireland.

Cancer Fund for Children has been supporting families for over forty years. They offer practical, emotional and financial help and also include stress-relieving, nurturing breaks at their therapeutic centre Daisy Lodge in County Down. Unfortunately, the overwhelming need has the centre operating at full capacity and created a long wait list for families.

This fundraising program will bring Daisy Lodge Connacht to the west of Ireland. This worthy project is supported by prominent Irish citizens such as professional golfer Rory McIlroy and will be attended by over 300 people including Paul Harrington, Bobby Kerr, Holly Carpenter and Eddie Irvine.

“HealthBeacon is delighted to be sponsoring this great event and worthy cause. The Cancer Fund for Children has ambitious plans for their new therapeutic centre in Mayo. This site will be entirely dedicated to support children and their families that have been diagnosed with cancer.” Jim Joyce, CEO HealthBeacon

For more information on the project, please see https://cancerfundforchildren.com/event/great-gatsby-gala-ball/

24 Oct

HealthBeacon attends Johnson & Johnson, JLABS CEO Summit

HealthBeacon are delighted to attend the 2nd annual JLABs CEO Summit in sunny La Jolla, San Diego. 

The event has gathered partners of Johnson & Johnson’s, JLABs group for two days of networking and information exchange as well as talks and panel discussions with industry leaders. 

HealthBeacon has been part of the global JLABs network after being chosen as the winner of the Johnson & Johnson Innovation, JLABS and Janssen Supply Chain Group, LLC (JSC) Patient Adherence QuickFire Challenge earlier this year.

Since winning the QuickFire Challenge, HealthBeacon has achieved FDA clearance for it’s smart sharps bin and launched in an additional four markets including the U.S. so there is a lot to catch up on with old friends and new at the event. 

This coupled with the growth of our product portfolio and data analytics platform offers a clear point of intersection within the JLABs ecosystem.

Having completed day one of the event which was focussed on JPAL & Investor Partnering we are excited to partake in the CEO Summit main program which began tonight featuring talks from J&J executives, JLABS CEOs, investors and industry leaders, and continues on Wednesday 24th.

 

10 Oct

HealthBeacon appoints Alan Dalton, Senior Manager of Contracts and Reimbursement

HealthBeacon today announced that Alan Dalton, formerly of VHI, Ireland’s largest private health insurer, has joined the HealthBeacon team as the senior manager of contracts and reimbursement.  Alan brings expert experience in both new businesses contracting and private health insurance reimbursement.

In his time with VHI, he negotiated contracts with hospital providers and medical device companies and supported the corporate proposition strategy team in VHI. Part of his role also included managing and driving the VHI service projects within the medical division and working closely with stakeholders of product development, marketing, legal, IT and finance.

Prior to his work with VHI, Alan spent over two years in Sydney working with the Evolution Healthcare Group, a private hospital operator in Australia and New Zealand, where he worked alongside the Executive Chairman in negotiating and developing agreements with device and pharma companies to drive value for the Evolution Group.

In his role, Alan will develop and introduce reimbursement models for both existing and new markets working alongside pharmaceutical and healthcare clients.

HealthBeacon is delighted to have Alan join the team and we look forward to the expertise he brings to our clients and partners.

27 Sep

HealthBeacon Opens New Production Facility

INNOVATIVE IRISH DIGITAL HEALTH COMPANY EXPANDS IRISH HEADQUARTERS

Today, Wednesday 26th September, Minister of State for Mental Health and Older People Jim Daly T.D. joined Irish digital health technology company HealthBeacon, to celebrate the official opening of their newly expanded Irish headquarters in Dublin 12.

HealthBeacon has been on an upward trajectory since founding in 2014, with 2018 their busiest year yet. Over the past four years the innovative Irish medtech company has experienced comprehensive market penetration within Ireland, witnessing in excess of 100% market growth.  HealthBeacon has doubled staffing over the last 18 months, now employing 30.  With offices in Ireland, Canada and the US, the business operates across 10 markets from the Headquarters in Dublin. The company was recently granted FDA (US Food and Drugs Administration) clearance and launched into the US market, which is worth hundreds of millions of dollars.

HealthBeacon develops smart tools for managing medication. The ‘Smart Sharps bin”, designed for injectable medication management, tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. The stand-alone device is bringing medtech into the ‘heart of the home’ helping to address one of the biggest unmet needs within the health arena – tracking patient’s real time usage and supporting chronic medicine schedules are maintained.

The expansion of HealthBeacon HQ makes way for advanced manufacturing processes and accommodate their growing data science team. The ground-breaking Irish company growth has been driven by global demand from the pharmaceutical industry and as such is increasing the technical capacity, customer care, warehouse and manufacturing space for both the production and the product development teams.

Speaking at the event, Jim Joyce, CEO of HealthBeacon added;

2018 has been a fast track year for HealthBeacon and today reflects our successes and our ongoing continued investment here in Ireland, our global HQ. The company has entered multiple new markets this year and received FDA clearance allowing us to enter the US market, with the world’s only Smart Sharps Adherence Platform. Looking forward, we are committed to continuing contributing to Ireland’s reputation as a global leader offering innovative best in class healthcare solutions.

The HealthBeacon system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into thousands of patients homes throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

HealthBeacon have worked closely with Enterprise Ireland since founding and were joined by Terence O’Rourke, Chairman, Enterprise Ireland today:

I am delighted to be at the opening of the HealthBeacon expanded production facility to support the company’s growth activities.  Working closely with Enterprise Ireland since 2014, HealthBeacon is designing and developing digital tools that impact positively on the lives of patients worldwide.

 The thriving Irish medtech sector continues its story of success and the development of innovative products such as the Smart Sharp Bin contribute significantly to Ireland’s reputation as a global leader in healthcare solutions. Our aim at Enterprise Ireland is to help businesses with global ambition to build scale and expand reach, and we will continue to work with HealthBeacon as it delivers medical solutions through innovation, underpinning the company’s continued growth in world markets.”

The opening event was attended by leaders from; medtech sector, executives from healthcare, pharmaceuticals, technology and finance.

Speaking before the launch, Minister for Health Simon Harris TD said; “Health research and innovation are an integral part of a well- functioning health service. Medical progress is directly linked to a strong health research community. We recognise that health research is a key factor in promoting the health of the population, combating disease, reducing disability and improving the quality of care. It can and does improve the quality of our health services and the quality of life of many in our society. It can do this by utilising research-led preventative strategies and deployment of services; by bringing the latest treatments to patients; by developing new models of care, and improving the efficiency and effectiveness of health care delivery.” 

Keynote speakers at the event who provided expertise on scaling healthcare technology companies in Ireland, included; Jim Joyce, CEO of HealthBeacon, Terence O’Rourke, Chairman of Enterprise Ireland, and Orla O’Gorman, Head of Equity Listing Ireland, EURONEXT.

17 Sep

HealthBeacon joins Irish Trade Mission in Brazil

Digital Therapeutic company, HealthBeacon, joined Irish and Brazilian Ministers for trade mission in São Paulo.

HealthBeacon joined Enterprise Ireland last week in São Paulo, Brazil with Irish Minister Pat Breen TD, Minister of State for Trade, Employment, Business, the EU Digital Single Market and Data Protection as part of a trade mission to Brazil. HealthBeacon and Minister Breen were hosted by AbbVie Pharmaceuticals at a working lunch with the key Brazilian government bodies in Education and Research as well as meeting with Brazil’s Minister of Science, Technology and Innovation, Mr. Gilberto Kassab. The Minister met with LATAM General Manager, Andrea Rangel, and North American Operations Director, Sean Glynn.

HealthBeacon has received full regulatory approval from Anatel and Anvisa to bring their smart sharps system into the Brazilian market. Brazil is a major market with millions of patients and is a key country in HealthBeacon’s global expansion strategy.  The Brazil launch will represent the first market in South America with additional LATAM markets implementing shortly.

Enterprise Ireland will be hosting this trade mission focusing on Irish trade in Brazil and Latin America.  Ireland is a proven innovation powerhouse, ranked a European leader for innovation in SMEs, employment impacts and sales impacts by the 2018 European Innovation Scoreboard:

  • Ireland is rated by Bloomberg as one of the top 15 most innovative nations in the world
  • Ireland ranks 11th globally for quality of its scientific research (Thomsson Reuters/Clarivate InCites, November 2017)
  • Ireland ranks 6th in the IMD World Competitiveness ranking
  • Ireland ranks 8th in Forbes Best Countries for Business ranking

 

Two-way trade between Ireland and Brazil continues to grow, with the combined trade in goods and services worth close to €1.8 billion in 2016. Irish Small and Medium Enterprises, such as those on this trade mission, have been shown a strong commitment to developing partnerships in the Brazilian market, increasing their sales here to over €42 million in 2017. 

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

10 Sep

HealthBeacon shortlisted as Supplier of the Year to the Pharma Industry

Digital Therapeutics company, HealthBeacon has been short listed in two categories at the Pharma Industry Awards.

The HealthBeacon Smart Sharps Platform has once again been nominated for their outstanding work with global pharmaceutical brands to support injectable medication treatments. HealthBeacon will defend their title of Pharma Project of the Year at the Pharma Industry Awards 2018. This year, HealthBeacon has also been short listed for another important award, Pharma Supplier of the Year. The Supplier of the Year award recognises a company or organisation that has provided a ‘best in class’ service, solution, product or goods to the Pharmaceutical industry. So far in 2018, HealthBeacon has received FDA clearance to enter the USA market, regulatory approval to bring HealthBeacon to Brazil and won multiple awards from the pharmaceutical industry.

Last year, HealthBeacon won the category for Pharma Project of the Year-Large and were shortlisted for Innovation of the Year. Since launching in 2014, the Pharma Industry Awards has established itself as the benchmark for excellence for those operating in Ireland’s pharma industry.

The Pharma Project of the Year award recognises an outstanding project undertaken in Ireland’s Pharma industry over the past 12 months. We believe the HealthBeacon project has received this special recognition due to the scale of the opportunity to impact the pharmaceutical industry. With billions of dollars spent annually, medication adherence is one of the most challenging issues facing the industry today.

The finalists will be present and the winners will be revealed at the gala awards ceremony on October 23rd at the Clayton Hotel Burlington Road, Dublin.

https://www.pharmaawards.ie/shortlist

 

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

09 Jul

HealthBeacon announces the US Launch of its FDA Cleared Adherence Device at MAGIC Foundation’s Annual Conference in Chicago



HealthBeacon partners with MAGIC Foundation to bring their innovative digital therapeutic technology to US patient group for human growth disorders.

(Dublin, Ireland; Chicago, IL, July 9th, 2018) HealthBeacon, a digital therapeutic leader in medication adherence, and the MAGIC Foundation, the world’s leading advocacy and information group for human growth disorders, has announced that their smart sharps platform will be made available to patients that are members of the MAGIC Foundation in the USA.

The MAGIC Foundation is a charitable non-profit organization created to provide support services for the families of children afflicted with a wide variety of chronic and/or critical disorders, syndromes and diseases that affect a child’s growth. HealthBeacon identified the MAGIC Foundation as their chosen partner to promote the MAGIC Foundation mission “to reduce the emotional and physical trauma caused by growth disorders, resulting in healthier, happier children and consequently, adults.”

HealthBeacon will be introduced to patients and carers at the MAGIC Foundation’s 24th Annual Conference in Illinois on July 12th, 2018. HealthBeacon’s injectable adherence platform has been cleared by the FDA, and this cornerstone event is the first step to make the HealthBeacon smart sharps system available to the millions of Americans on long term, chronic injectable care. This major launch event will kick off HealthBeacon’s US Tour to introduce their digital therapeutic platform to influencers and advocates nationwide.

MAGIC Foundation is the global leader in endocrine health, advocacy, education, and support. HealthBeacon believes that engaging with the world leading advocacy groups will provide a strong network and patient engagement program to improve medication adherence for patients with human growth disorders.

“MAGIC Foundation is so pleased to offer our patients such an impactful and innovative solution to help with their treatment programs.  We appreciate and always welcome ways to improve the lives and the care of our patients and their families.” Dianne Kremidas, Executive Director at The MAGIC Foundation.

Since launching commercially in Europe, in 2013, HealthBeacon currently serves thousands of patients across 10 markets in Canada, Europe, the Middle East and South America.

About HealthBeacon
HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

About MAGIC Foundation
The MAGIC Foundation was incorporated in the state of Illinois and received 501(C)3 non-profit status October 29, 1989. Since its inception the Foundation has grown to include support services for adults who were also impacted by these disorders.

24 May

HealthBeacon Obtains FDA Clearance for the World’s First Smart Sharps Adherence Device



Digital Therapeutic company HealthBeacon receives 510K FDA clearance to provide smart sharps bins to US patients

(Dublin, Ireland; Boston, MA) HealthBeacon, a digital therapeutic innovator, announced today that they have received clearance by the United States Food and Drug Administration (FDA) to offer the HealthBeacon smart sharps bin to patients using injectable medications in the US.

HealthBeacon’s injectable adherence platform has been cleared by the FDA, and will be available for the first time to the millions of Americans on long term, chronic injectable care. HealthBeacon anticipates the US commercial launch of its platform later this summer.

Since launching commercially in Europe, in 2013, HealthBeacon currently serves thousands of patients across 10 markets in Canada, Europe, the Middle East and South America.

HealthBeacon CEO, Jim Joyce, has stated, “Working with the FDA over the last year, and ultimately receiving FDA clearance is a defining moment for HealthBeacon as a company. We are excited to launch in the US later this summer.”

The digital therapeutic market has reached significant landmarks in the last year, and HealthBeacon joins a small but elite number of digital therapeutic organizations with validated technology that have received FDA clearance.

Robert K. Coughlin, President and CEO of MassBio has commented, “I am delighted to hear HealthBeacon has received FDA Clearance for their novel medical technology, and has chosen Boston to launch their U.S. operations. There is no better place in the world for the life sciences, and we’re thrilled to welcome a company that will bring further value to the healthcare system and to patients.”

Dublin, Ireland based HealthBeacon has strong ties to the US, as it is founded by Irish-American and native Bostonian Jim Joyce. This connection has strengthened since opening their first US based office in Boston in March of 2017.

This clearance is part of HealthBeacon’s regulatory strategy to make its technology available globally. This follows on HealthBeacon’s recent announcement of approval for the Brazilian market.

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

© 2015 Health Beacon - Privacy Policy - Website by Medusa